Developmental origins of health and disease: experimental and human evidence of fetal programming for metabolic syndrome. 2012

M L de Gusmão Correia, and A M Volpato, and M B Águila, and C A Mandarim-de-Lacerda
Department of Anatomy, Institute of Biology, State University of Rio de Janeiro, Rio de Janeiro, Brazil.

The concept of developmental origins of health and disease has been defined as the process through which the environment encountered before birth, or in infancy, shapes the long-term control of tissue physiology and homeostasis. The evidence for programming derives from a large number of experimental and epidemiological observations. Several nutritional interventions during diverse phases of pregnancy and lactation in rodents are associated with fetal and neonatal programming for metabolic syndrome. In this paper, recent experimental models and human epidemiological studies providing evidence for the fetal programming associated with the development of metabolic syndrome and related diseases are revisited.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007236 Infant, Small for Gestational Age An infant having a birth weight lower than expected for its gestational age.
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002318 Cardiovascular Diseases Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM. Adverse Cardiac Event,Cardiac Events,Major Adverse Cardiac Events,Adverse Cardiac Events,Cardiac Event,Cardiac Event, Adverse,Cardiac Events, Adverse,Cardiovascular Disease,Disease, Cardiovascular,Event, Cardiac
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D047109 Fetal Development Morphological and physiological development of FETUSES. Fetal Programming,Fetal Growth,Development, Fetal,Fetal Programmings,Growth, Fetal
D050356 Lipid Metabolism Physiological processes in biosynthesis (anabolism) and degradation (catabolism) of LIPIDS. Metabolism, Lipid
D024821 Metabolic Syndrome A cluster of symptoms that are risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components of metabolic syndrome include ABDOMINAL OBESITY; atherogenic DYSLIPIDEMIA; HYPERTENSION; HYPERGLYCEMIA; INSULIN RESISTANCE; a proinflammatory state; and a prothrombotic (THROMBOSIS) state. Cardiometabolic Syndrome,Insulin Resistance Syndrome X,Metabolic Syndrome X,Reaven Syndrome X,Dysmetabolic Syndrome X,Metabolic Cardiovascular Syndrome,Metabolic X Syndrome,Syndrome X, Insulin Resistance,Syndrome X, Metabolic,Cardiometabolic Syndromes,Cardiovascular Syndrome, Metabolic,Cardiovascular Syndromes, Metabolic,Metabolic Syndromes,Syndrome X, Dysmetabolic,Syndrome X, Reaven,Syndrome, Cardiometabolic,Syndrome, Metabolic,Syndrome, Metabolic Cardiovascular,Syndrome, Metabolic X,Syndromes, Cardiometabolic,Syndromes, Metabolic,X Syndrome, Metabolic

Related Publications

M L de Gusmão Correia, and A M Volpato, and M B Águila, and C A Mandarim-de-Lacerda
April 2005, Physiological reviews,
M L de Gusmão Correia, and A M Volpato, and M B Águila, and C A Mandarim-de-Lacerda
September 2006, American journal of physiology. Endocrinology and metabolism,
M L de Gusmão Correia, and A M Volpato, and M B Águila, and C A Mandarim-de-Lacerda
April 2017, The American journal of psychiatry,
M L de Gusmão Correia, and A M Volpato, and M B Águila, and C A Mandarim-de-Lacerda
January 2012, Annual review of physiology,
M L de Gusmão Correia, and A M Volpato, and M B Águila, and C A Mandarim-de-Lacerda
January 2019, Biological psychiatry,
M L de Gusmão Correia, and A M Volpato, and M B Águila, and C A Mandarim-de-Lacerda
May 2013, Cellular and molecular life sciences : CMLS,
M L de Gusmão Correia, and A M Volpato, and M B Águila, and C A Mandarim-de-Lacerda
November 2002, Trends in endocrinology and metabolism: TEM,
M L de Gusmão Correia, and A M Volpato, and M B Águila, and C A Mandarim-de-Lacerda
April 2017, Taiwanese journal of obstetrics & gynecology,
M L de Gusmão Correia, and A M Volpato, and M B Águila, and C A Mandarim-de-Lacerda
October 2015, Frontiers in neuroendocrinology,
Copied contents to your clipboard!